Cardiovascular Risk Profile and Antihypertensive Treatment

Cardiovascular Risk Profile and Antihypertensive Treatment

Blood pressure–lowering treatment reduces cardiovascula risk. However, individuals treated with antihypertensive medication had primarily worse prognosis for cardiovascular diseases than untreated hypertensive or normotensive population. Although the strong positive relationship between blood pressure level and cardiovascular disease risks were observed among general population, there is little argument as to the risk increase with elevation of blood pressure among treated participants.

 

    Related Conference of Cardiovascular Risk Profile and Antihypertensive Treatment

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Cardiovascular Risk Profile and Antihypertensive Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in